Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01884740
Title Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux and Bevacizumab For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Weill Medical College of Cornell University

malignant astrocytoma



brain stem glioma


Bevacizumab + Cetuximab

Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
Weill Cornell Medical College/New York Presbyterian Hospital Recruiting New York New York 10001 United States Details
*Shaded cells indicate that there was no data available from for the field